What is the CIC achieving?
- identifying potential therapies
- partnering with industry
- supporting small biotech companies
- facilitating investment decisions
- publishing novel data
- expanding capacity
Since 2005, the CIC has risen to prominence as a leader in research and related drug development for asthma and other airways diseases.
In collaboration with industry scientists, CIC delivers highly sought-after, niche clinical trial services to large and small pharmaceutical, biotech and biopharma companies. CIC has established major, ongoing industrial partnerships with biopharmaceutical companies including Amgen, AstraZeneca, Genentech, Novartis, Pfizer, Schering Plough, and Wyeth, and with small biotechnological companies from Canada and the USA.
The CIC has put Canada on the map as a leader in research and related drug development for asthma and other airways diseases.
.